Biogen Announces Upcoming Kidney Presentations at European Renal Association and American Transplant CongressesGlobeNewsWire • 06/03/26
UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus ErythematosusGlobeNewsWire • 06/01/26
Should You Buy, Sell or Hold BIIB Stock After it Rises Almost 12% YTD?Zacks Investment Research • 05/29/26
Biogen Inc. (BIIB) Investors with Losses are Urged to Contact The Gross Law Firm to Discuss Their RightsGlobeNewsWire • 05/29/26
Italy's antitrust regulator opens probe into US Biogen over alleged dominant positionReuters • 05/27/26
Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson's DiseaseGlobeNewsWire • 05/21/26
Levi & Korsinsky Announces Investigation of Securities Claims Against Biogen Inc. (BIIB)GlobeNewsWire • 05/20/26
BIIB Investor Alert: Levi & Korsinsky Investigates Biogen Inc. (BIIB) for Potential Securities FraudBusiness Wire • 05/19/26
BIIB ALERT: Levi & Korsinsky Investigates Biogen Inc. for Possible Securities Fraud ViolationsNewsfile Corp • 05/18/26
BIIB SHAREHOLDER INVESTIGATION: SueWallSt Investigates Biogen Inc. for Possible Securities Law ViolationsPRNewsWire • 05/18/26
Biogen Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Biogen Inc. (BIIB)PRNewsWire • 05/15/26
Investigation Alert: Biogen Inc. (BIIB) Under Scrutiny - Contact Levi & Korsinsky for DetailsNewsfile Corp • 05/15/26
BIIB Advances Alzheimer's Disease Drug Despite Study Missing Main GoalZacks Investment Research • 05/15/26
Biogen: Apellis Acquisition, Alzheimer's Fail Sums Up Mixed Investment OpportunitySeeking Alpha • 05/15/26
Biogen Is Celebrating A First In Alzheimer's Disease. But Investors Are Leery.Investors Business Daily • 05/14/26